AP2 | Early Access post-MA

Q: AP2 | Early Access post-MA

Early Access post-MA AP2 (Early Access post-MA) enables patients to benefit from a medicine after European marketing authorisation but before reimbursement in France. It ensures rapid access to medical innovations while gathering additional safety and efficacy data. AP2 is part of France’s broader early access framework .

Early Access post-MA

AP2 (Early Access post-MA) enables patients to benefit from a medicine after European marketing authorisation but before reimbursement in France.

It ensures rapid access to medical innovations while gathering additional safety and efficacy data. AP2 is part of France’s broader early access framework.